| Literature DB >> 32192012 |
Anaïs Fournier1, Bruno Gauthier2, Marie-Claude Guay3, Véronique Parent1.
Abstract
BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is often associated with frontal executive impairment in children. Oppositional defiant disorder (ODD) and anxiety disorders (AD) frequently accompany ADHD, but the impact of these comorbid disorders on cognition remains elusive. The five-point test (FPT), a design fluency task, has been shown to be sensitive to neurological damage, specifically to frontal lobe lesions in patients with brain injuries. The purpose of this study was to compare the performances of neurotypical children with that of children with ADHD, ADHD-ODD, and ADHD-AD on the FPT in order to examine whether these groups could be distinguished from one another based on their cognitive profile.Entities:
Keywords: anxiety disorders; attention deficit and disruptive behavior disorders; developmental disabilities; executive function; oppositional defiant disorder
Year: 2020 PMID: 32192012 PMCID: PMC7139708 DOI: 10.3390/brainsci10030172
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Participant demographics by group.
| Control | ADHD | ADHD-ODD | ADHD-AD | ||
|---|---|---|---|---|---|
| ( | ( | ( | ( | Comparisons | |
| Age: mean (SD) | 10.03 (1.06) | 9.63 (0.86) | 9.73 (0.99) | 9.38 (1.02) | ns |
| Gender: male | 16 (47.06) | 26 (66.67) | 16 (80.00) | 14 (77.78) | Control < Clinical |
| Medication: active | n/a | 21 (53.85) | 12 (60.00) | 10 (55.56) | ns |
| ADHD symptoms | 32.44 | 92.08 | 94.70 | 88.50 | Control < Clinical |
| ADHD symptoms | 24.03 | 70.86 | 72.60 | 62.06 | Control < Clinical |
SD: standard deviation; n/a = not applicable; ns = not significant; ADHD = attention deficit/hyperactivity disorder; ADHD-ODD = ADHD with associated oppositional defiant disorder; ADHD-AD = ADHD with associated anxiety disorder. Medication is essentially long action psychostimulants. ADHD symptoms (in percentile) measured with ADHD Rating Scale IV (ARS-IV).
Figure 1Example of stimuli from the five-point test. The complete test consists of 40 five-point rectangles arranged in 8 rows of 5 rectangles on an 8 ½ × 11 inches sheet.
Pearson correlation coefficients for age, gender, medication, and FPT scores.
| 1 | 2 a | 3 b | 4 | 5 | 6 | 7 | 8 | 9 | |
|---|---|---|---|---|---|---|---|---|---|
| 1. Age | – | ||||||||
| 2. Gender | −0.192 * | – | |||||||
| 3. Medication | 0.036 | −0.075 | – | ||||||
| 4. TD | 0.290 ** | 0.085 | 0.169 | – | |||||
| 5. CD | 0.467 *** | −0.041 | 0.143 | 0.844 *** | – | ||||
| 6. RD | −0.144 | 0.217 * | 0.116 | 0.620 *** | 0.102 | – | |||
| 7. RT | −0.282 ** | 0.227 * | 0.057 | 0.304 ** | −0.223 * | 0.888 *** | – | ||
| 8. RC | −0.290 ** | 0.203 * | 0.014 | 0.256 ** | −0.254 ** | 0.846 *** | 0.968 *** | – | |
| 9. TS | 0.482 *** | −0.126 | 0.091 | 0.651 *** | 0.746 *** | 0.117 | −0.063 | −0.062 | – |
a Point-biserial correlation (0 = female; 1 = male); b Point-biserial correlation for clinical groups only (0 = unmedicated; 1 = medicated). FPT = five-point test; TD = total designs; CD = correct designs; RD = repeated designs; RT = repeated on total designs; RC = repeated on correct designs; TS = total number of strategy designs. * p < 0.05; ** p < 0.01; *** p < 0.001.
Performance and group differences across the FPT measures.
| Mean (SD) and Adjusted Mean (SE) for Age * for Each Group | |||||||
|---|---|---|---|---|---|---|---|
| Control | ADHD | ADHD-ODD | ADHD-AD |
|
| η² | |
| FPT Measure | |||||||
| TD | 34.53 (9.45) | 35.77 (11.56) | 40.20 (15.17) | 27.22 (9.87) | |||
| 33.52 (1.92) | 36.11 (1.77) | 40.20 (2.47) a | 28.38 (2.63) a | 3.94 | 0.010 | 0.100 | |
| CD | 31.12 (8.84) | 30.46 (8.74) | 29.55 (9.46) | 22.72 (9.85) | |||
| 29.85 (1.42) | 30.89 (1.31) a | 29.56 (1.83) | 24.18 (1.95) a | 2.86 | 0.41 | 0.075 | |
| RD | 3.41 (3.93) | 5.31 (5.97) | 10.65 (9.34) | 4.50 (4.59) | |||
| 3.46 (1.07) c | 5.27 (0.97) a | 10.65 (1.35) a | 4.01 (1.50) a | 6.28 | 0.001 | 0.151 | |
| TS | 11.06 (8.35) | 11.26 (7.41) | 9.25 (4.93) | 8.83 (8.49) | |||
| 9.92 (1.16) | 11.64 (1.06) | 9.26 (1.48) | 10.14 (1.58) | 0.71 | 0.546 | 0.020 | |
| RT | 9.39 (9.43) | 13.18 (11.83) | 24.05 (16.23) | 16.75 (16.42) | |||
| 10.50 (2.20) f | 12.80 (2.00) a | 24.00 (2.80) a | 15.50 (3.00) | 5.30 | 0.002 | 0.131 | |
| RC | 11.97 (16.20) | 17.86 (20.71) | 38.46 (34.09) | 26.73 (37.22) | |||
| 14.20 (4.30) a | 17.10 (4.00) a | 38.50 (5.50) a | 24.20 (5.90) | 4.55 | 0.005 | 0.114 | |
SD: standard deviation; SE: standard error; *, The covariate in the model is evaluated using the value: age = 9.73. FPT = five-point test; TD = total designs; CD = correct designs; RD = repeated designs; TS = strategy designs; RT = repeated on total designs; RC = repeated on correct designs. Superscript a, c, f indicate statistically significant differences between groups after adjustment for multiple comparisons (Bonferroni).